2016 discharge: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

This decision concerns the 2016 discharge for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Competing amendments would grant or postpone discharge, and address weaknesses in IT-project management, a framework contract whose ceiling was exceeded, the appointment of an authorising officer to evaluation committees, the protection of whistle-blowers, near-balanced gender ratios in posts, the Centre's long-term strategy, and improved access to its data on drugs.